A pilot open trial evaluating the efficacy of low-dose aminopterin in the canine homologue of human atopic dermatitis [1]

British Journal of Dermatology

Volumn 157, Issue 5, 2007, Pages 1040-1042

  Olivry, T ^a   Paps, J S ^a   Bizikova, P ^a   Murphy, K M ^a   Jackson, H A ^a   Zebala, J ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b SYNTRIX BIOSYSTEMS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPTERIN; CYCLOSPORIN; GLUCOCORTICOID; METHOTREXATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ATOPIC DERMATITIS; DRUG BIOAVAILABILITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; LETTER; NONHUMAN; PRIORITY JOURNAL; PSORIASIS;

AMINOPTERIN; ANIMALS; DERMATITIS, ATOPIC; DOG DISEASES; DOGS; FOLIC ACID ANTAGONISTS; HUMANS; MODELS, ANIMAL; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 35348885050     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08133.x     Document Type: Letter

References (10)

1. Cronstein BN, Naime D, Ostad E. The antiinflammatory effects of methotrexate are mediated by adenosine. Adv Exp Med Biol 1994 370 : 411 16.
2. Chan ES, Cronstein BN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res 2002 4 : 266 73.
3. Strober BE, Siu K, Menon K. Conventional systemic agents for psoriasis. A systematic review. J Rheumatol 2006 33 : 1442 6.
4. Goujon C, Berard F, Dahel K et al. Methotrexate for the treatment of adult atopic dermatitis. Eur J Dermatol 2006 16 : 155 8.
5. Weatherhead SC, Wahie S, Reynolds NJ et al. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema. Br J Dermatol 2007 156 : 346 51.
6. Cole PD, Zebala JA, Alcaraz MJ et al. Pharmacodynamic properties of methotrexate and aminotrexate during weekly therapy. Cancer Chemother Pharmacol 2006 57 : 826 34.
7. Marsella R, Olivry T. Animal models of atopic dermatitis. Clin Dermatol 2003 21 : 122 33.
8. DeBoer DJ, Hillier A. The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis. Vet Immunol Immunopathol 2001 81 : 271 6.
9. Olivry T, Marsella R, Iwasaki T et al. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Vet Dermatol 2007 18 : 79 96.
10. Philips FS, Thiersch JB, Ferguson FC. Studies of the action of 4-aminopteroylglutamic acid and its congeners in mammals. Ann N Y Acad Sci 1950 52 : 1349 59.